Electromed (ELMD) EBIT Margin Growth (3y) (2013 - 2026)

Electromed (ELMD) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 180.89 Bn 173.59 Bn 6.27 Bn -343.00
2 Stryker 127.82 Bn 124.94 Bn 3.81 Bn 17.00
3 Medtronic 107.49 Bn 98.27 Bn 6.41 Bn 78.00
4 Boston Scientific 67.24 Bn 65.78 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 48.02 Bn 44.34 Bn 1.29 Bn -283.00
6 Dexcom 28.25 Bn 27.14 Bn 750.30 Mn 1,505.00
7 GE HealthCare Technologies 28.17 Bn 25.89 Bn 1.98 Bn -184.00
8 Smith & Nephew 26.72 Bn 26.14 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn 2,016.00
10 Electromed 320.16 Mn 303.17 Mn 14.64 Mn 1,036.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,036.00
Dec 31, 2025 829.00
Sep 30, 2025 1,540.00
Jun 30, 2025 1,309.00
Mar 31, 2025 513.00
Dec 31, 2024 514.00
Sep 30, 2024 783.00
Jun 30, 2024 886.00
Mar 31, 2024 1,051.00
Dec 31, 2023 -14.00
Sep 30, 2023 -713.00
Jun 30, 2023 -777.00
Mar 31, 2023 -53.00
Dec 31, 2022 -747.00
Sep 30, 2022 -1,583.00
Jun 30, 2022 -1,291.00
Mar 31, 2022 224.00
Dec 31, 2021 208.00
Sep 30, 2021 261.00
Jun 30, 2021 -918.00